Jefferies Financial Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-34,027
Closed -$1.23M – 1466
2026
Q2
$1.23M Buy
+34,027
New +$998K 0.01% 880
2026
Q1
– Sell
-118,300
Closed -$2M – 1880
2025
Q4
$2M Buy
118,300
+29,860
+34% +$525K 0.01% 809
2025
Q3
$1.92M Buy
+88,440
New +$1.47M 0.01% 658
2025
Q2
– Sell
-10,000
Closed -$130K – 1465
2025
Q1
$130K Hold
10,000
– – ﹤0.01% 1445
2024
Q4
$133K Buy
+10,000
New +$101K ﹤0.01% 1436

Other funds holding ETON

Jefferies Financial Group's ETON Position: Q3 2026 in Review

Jefferies Financial Group sold out of Eton Pharmaceutcials (ETON) in Q3 2026, closing a stake of 34,027 shares — an estimated $1.23M sold.

Jefferies Financial Group first reported a position in ETON in Q4 2024 and held it in 5 quarters. The position peaked at $2M in Q4 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Jefferies Financial Group reported no remaining Eton Pharmaceutcials position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 34,027 Eton Pharmaceutcials shares in Q3 2026, an estimated $1.23M.
  • Jefferies Financial Group first reported a position in Eton Pharmaceutcials in Q4 2024 and held it in 5 quarters.
  • Jefferies Financial Group's Eton Pharmaceutcials position peaked at $2M in Q4 2025.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.